Michael L. Baur - Nov 14, 2024 Form 4 Insider Report for SCANSOURCE, INC. (SCSC)

Role
CEO & Chairman of the Board, Director
Signature
J. Creighton Lynes, attorney-in-fact
Stock symbol
SCSC
Transactions as of
Nov 14, 2024
Transactions value $
-$1,716,543
Form type
4
Date filed
11/18/2024, 08:00 PM
Previous filing
Sep 4, 2024
Next filing
Nov 21, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SCSC Common Stock Options Exercise $34.6K +1.4K +0.79% $24.68 179K Nov 14, 2024 Direct F1
transaction SCSC Common Stock Sale -$68.5K -1.4K -0.78% $48.91 178K Nov 14, 2024 Direct F1, F2
transaction SCSC Common Stock Options Exercise $696K +28.2K +15.87% $24.68 206K Nov 14, 2024 Direct F1
transaction SCSC Common Stock Sale -$1.39M -28.2K -13.7% $49.21 178K Nov 14, 2024 Direct F1, F3
transaction SCSC Common Stock Options Exercise $624K +25.3K +14.23% $24.68 203K Nov 15, 2024 Direct F1
transaction SCSC Common Stock Sale -$1.24M -25.3K -12.46% $48.99 178K Nov 15, 2024 Direct F1, F4
transaction SCSC Common Stock Options Exercise $372K +15.1K +8.48% $24.68 193K Nov 18, 2024 Direct F1
transaction SCSC Common Stock Sale -$748K -15.1K -7.82% $49.57 178K Nov 18, 2024 Direct F1, F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SCSC Employee Stock Option (Right to Buy) Options Exercise $0 -29.6K -22.12% $0.00 104K Nov 14, 2024 Common Stock 29.6K $24.68 Direct F1, F6
transaction SCSC Employee Stock Option (Right to Buy) Options Exercise $0 -25.3K -24.26% $0.00 79K Nov 15, 2024 Common Stock 25.3K $24.68 Direct F1, F6
transaction SCSC Employee Stock Option (Right to Buy) Options Exercise $0 -15.1K -19.09% $0.00 63.9K Nov 18, 2024 Common Stock 15.1K $24.68 Direct F1, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 The transactions covered by this Form 4 have been effected pursuant to a Rule 10b5-1 Sales Plan adopted by the reporting person on September 1, 2023.
F2 The price reported in column 4 is the weighed average price. These shares were sold in multiple transactions at prices ranging from $48.87 to $48.97 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price reported in column 4 is the weighed average price. These shares were sold in multiple transactions at prices ranging from $49.00 to $49.99 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 The price reported in column 4 is the weighed average price. These shares were sold in multiple transactions at prices ranging from $48.49 to $49.49 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F5 The price reported in column 4 is the weighed average price. These shares were sold in multiple transactions at prices ranging from $49.14 to $50.01 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F6 The option vested in one-third increments on the anniversary of the grant date on 11/19/2021, 11/19/2022 and 11/19/2023.